Skip to content
healthcare.dev
Get a free key

Carbinoxamine Maleate Extended-Release Oral Suspension

NDC 62542-101, Carbinoxamine Maleate, suspension, extended release, from Neos Therapeutics, LP.

Product NDC
62542-101
Status
Listed
Labeler
Neos Therapeutics, LP
Dosage form
SUSPENSION, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA022556
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62542-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CARBINOXAMINE MALEATE4 mg/5mL

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
62542-101-0562542010105480 mL in 1 BOTTLE, PLASTIC (62542-101-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/199f46e5-6288-5627-e063-6294a90ae086

  • NADAC price for package 62542010105

    GET /v1/drugs/nadac/62542010105

Use it

Look up 62542-101 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62542-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62542-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.